CoChat

Amyotrophic Lateral Sclerosis: Current and Future Treatment Strategies

Festoff, Barry W. · 1996 · Drugs

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

Abstract

Amyotrophic lateral sclerosis (ALS) is a fatal, enigmatic disorder characterised by relentless progression of muscle wasting and weakness until death ensues due to respiratory muscle failure. Intellectual functions are usually spared. ALS, known also as motor neuron disease (MND) in the UK, maladie de Charcot in France and Lou Gehrig's disease in the US, is usually sporadic, but between 5 and 10% of all cases are hereditary, usually inherited as autosomal dominant. Previously thought to be untreatable, as well as incurable, just in the last 3 years ALS has been the greatest clinical application of recent exciting break-throughs in preclinical neurobiology research. Although definitive information regarding the cause(s) and pathogenesis of ALS still escapes us, meaningful demonstration of intercession in the downhill course with specific therapy has been suggested, giving reason to be hopeful, if cautiously and critically optimistic. This review focuses on the recent work from the fields of growth/trophic factors, glutamate/neurotoxicity, neuroprotection and proteases and inhibitors, as well as the approaches to measuring specific effects in patients with the illness. It ends with a eye to the horizon, and the future, and where ALS treatment strategies may be heading after the millennium.

Overview

Integrity signals

Registry

Crossref · 10.2165/00003495-199651010-00004

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 111 references

Cited by

See all 35

Metadata

Authors
Festoff, B. W.
Affiliations
University of Kansas (US)
Corresponding author
Festoff, Barry W.
Venue
Drugs
Published
1996-01
Volume
51
Issue
1
Pages
28-44
ISSN
0012-6667 (ISSN-L)
OpenAlex
W2121497477
Cited by
35
References
110
Citations by year
2016: 1 · 2014: 3 · 2013: 2 · 2012: 1
FWCI
3.43
Type
journal article
Language
en
Open access
closed
Locations
  • Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
amyotrophic lateral sclerosis, motor neuron disease, sporadic ALS, ALS pathogenesis, ALS treatment, neuroprotection, growth factors, trophic factors, glutamate excitotoxicity, proteolytic enzymes, protease inhibitors, muscle atrophy, respiratory muscle failure, biomarkers
MeSH terms
Amyotrophic Lateral Sclerosis, Clinical Trials as Topic, Humans, Insulin-Like Growth Factor I, Nerve Tissue Proteins, Thiazoles, Apoptosis, Riluzole, Ciliary Neurotrophic Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyotrophic Lateral Sclerosis: Current and Future Treatment Strategies. https://app.cochat.ai/papers/10.2165/00003495-199651010-00004
The paper
Festoff, B. W. (1996). Amyotrophic Lateral Sclerosis: Current and Future Treatment Strategies. Drugs. https://doi.org/10.2165/00003495-199651010-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.